Assignee
INTEGRATED BIOTHERAPEUTICS INC
US·8 granted patents·6 pending applications·16 citations·filing 2012–2021
Top patents by PatentIndex Score
14 records- 0189US11028153B2Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysinsINTEGRATED BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 8, 2021·4 cites·20 claims
- 0282US10487140B2Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysinsINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Granted Nov 26, 2019·5 cites·27 claims
- 0373US11135280B2Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivityINTEGRATED BIOTHERAPEUTICS INC·Filed 2017·Granted Oct 5, 2021·2 cites·13 claims
- 0471US9815872B2Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereofINTEGRATED BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 14, 2017·2 cites·11 claims
- 0570US10174085B2Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereofINTEGRATED BIOTHERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·1 cites·23 claims
- 0665US10611827B2Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteinsINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Granted Apr 7, 2020·1 cites·11 claims
- 0761US10023848B2Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptidesINTEGRATED BIOTHERAPEUTICS INC·Filed 2012·Granted Jul 17, 2018·1 cites·21 claims
- 0843US2023235029A1Broadly neutralizing binding molecules against marburgvirusesINTEGRATED BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0942US11186626B2Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loopINTEGRATED BIOTHERAPEUTICS INC·Filed 2017·Granted Nov 30, 2021·0 cites·12 claims
- 1037US2016039888A1Immunogenic composition comprising alpha-hemolysin oligopeptidesINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1136US2018141981A1Immunogenic composition comprising engineered alpha-hemolysin oligopeptidesINTEGRATED BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1234US2018022790A1Equine immunoglobulin compositions and uses for treating filovirus-mediated diseasesINTEGRATED BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1331US2018237502A1Pan-ebola and pan-filovirus protective epitopes, antibodies, and antibody cocktailsINTEGRATED BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1431US2017158753A1Monoclonal antibodies directed against envelope glycoproteins from multiple filovirus speciesINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INTEGRATED BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →